Clinical spectrum of SCN2A mutations expanding to Ohtahara syndrome
Male
NAV1.2 Voltage-Gated Sodium Channel
Infant, Newborn
Brain
Infant
Electroencephalography
Magnetic Resonance Imaging
3. Good health
03 medical and health sciences
0302 clinical medicine
Mutation
Humans
Female
Spasms, Infantile
DOI:
10.1212/wnl.0b013e3182a43e57
Publication Date:
2013-08-10T04:43:15Z
AUTHORS (31)
ABSTRACT
<h3>Objective:</h3> We aimed to investigate the possible association between <i>SCN2A</i> mutations and early-onset epileptic encephalopathies (EOEEs). <h3>Methods:</h3> recruited a total of 328 patients with EOEE, including 67 Ohtahara syndrome (OS) 150 West syndrome. were examined using high resolution melt analysis or whole exome sequencing. <h3>Results:</h3> found 14 novel missense in 15 patients: 9 OS cases (13.4%), 1 (0.67%), 5 111 unclassified EOEEs (4.5%). Twelve confirmed as de novo, all absent 212 control exomes. A novo mosaic mutation (c.3976G>C) mutant allele frequency 18% was detected one patient. One (c.634A>G) transcript variant 3, which is neonatal isoform. All located linker regions 2 transmembrane segments. In 7 OS, EEG findings transitioned from suppression-burst pattern hypsarrhythmia. had intractable seizures; 3 them seizure-free at last medical examination. showed severe developmental delay. <h3>Conclusions:</h3> Our study that are an important genetic cause OS. Given wide clinical spectrum associated mutations, testing for should be considered children different conditions.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (40)
CITATIONS (166)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....